PNM7 A COST-EFFECTIVENESS ANALYSIS OF ELETRIPTAN 40MG AND 80MG VERSUS SUMATRIPTAN 50MG AND 100MG IN THE ACUTE TREATMENT OF MIGRAINE
Nov 1, 2003, 00:00
10.1016/S1098-3015(10)61946-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)61946-8/fulltext
Title :
PNM7 A COST-EFFECTIVENESS ANALYSIS OF ELETRIPTAN 40MG AND 80MG VERSUS SUMATRIPTAN 50MG AND 100MG IN THE ACUTE TREATMENT OF MIGRAINE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61946-8&doi=10.1016/S1098-3015(10)61946-8
First page :
Section Title :
Open access? :
No
Section Order :
392